Showing results (81-90 of 95) with videos related to
Sort By:
Pageof 10
Neurobiology of Disease|December 26, 2025
Reduced cortico-muscular output is associated with intrinsic hypoexcitability and reduced persistent inward currents in motor cortex neurons of TDP-43Q331K ALS miceJose A Viteri, Nathan R Kerr, Charles D Brennan, et al.Frontiers in Neuroscience|August 1, 2020
Second Harmonic Generation Imaging of Collagen in Chronically Implantable Electrodes in Brain TissueCorinne R Esquibel, Kristy D Wendt, Heui C Lee, et al.Journal of Medicinal Chemistry|April 26, 2000
Structure-activity studies for a novel series of tricyclic substituted hexahydrobenz[e]isoindole alpha(1A) adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia (BPH)M D Meyer, R J Altenbach, F Z Basha, et al.Bioorganic & Medicinal Chemistry Letters|March 30, 2007
Discovery of a novel small molecule binding site of human survivinMichael D Wendt, Chaohong Sun, Aaron Kunzer, et al.Bioorganic & Medicinal Chemistry Letters|December 8, 2004
Naphthamidine urokinase plasminogen activator inhibitors with improved pharmacokinetic propertiesMilan Bruncko, William J McClellan, Michael D Wendt, et al.Journal of Medicinal Chemistry|June 1, 2001
Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasiaM D Meyer, R J Altenbach, H Bai, et al.Journal of Medicinal Chemistry|October 10, 2008
Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteinsCheol-Min Park, Milan Bruncko, Jessica Adickes, et al.Journal of Medicinal Chemistry|February 3, 2006
Discovery and structure-activity relationship of antagonists of B-cell lymphoma 2 family proteins with chemopotentiation activity in vitro and in vivoMichael D Wendt, Wang Shen, Aaron Kunzer, et al.Journal of Medicinal Chemistry|January 30, 2007
Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xLMilan Bruncko, Thorsten K Oost, Barbara A Belli, et al.Chemical Biology & Drug Design|July 17, 2007
Discovery and design of novel HSP90 inhibitors using multiple fragment-based design strategiesJeffrey R Huth, Chang Park, Andrew M Petros, et al.Pageof 10